We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGS
11101
PUT
DELISTED
PlayAGS
AGS
$121K ﹤0.01%
23,500
-2,600
-10% -$15.1K
AIRG icon
11102
Airgain
AIRG
$72.2M
$121K ﹤0.01%
14,927
+1,934
+15% +$17.4K
ANGI icon
11103
PUT
Angi Inc
ANGI
$191M
$121K ﹤0.01%
2,650
-1,280
-33% -$62.8K
CPRX
11104
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$121K ﹤0.01%
+17,300
New +$127K
KYN icon
11105
CALL
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$121K ﹤0.01%
14,400
-4,700
-25% -$42.6K
MVST icon
11106
PUT
Microvast
MVST
$322M
$121K ﹤0.01%
54,600
-33,800
-38% -$145K
NUV icon
11107
Nuveen Municipal Value Fund
NUV
$1.9B
$121K ﹤0.01%
13,544
+1,813
+15% +$16.4K
PRM icon
11108
Perimeter Solutions
PRM
$5.55B
$121K ﹤0.01%
11,203
-316,461
-97% -$3.37M
SCM icon
11109
Stellus Capital Investment Corp
SCM
$250M
$121K ﹤0.01%
+10,897
New +$141K
SLQT icon
11110
PUT
SelectQuote
SLQT
$129M
$121K ﹤0.01%
48,700
-58,100
-54% -$149K
UXIN
11111
Uxin Ltd
UXIN
$260M
$121K ﹤0.01%
2,877
+2,146
+294% +$129K
NPKI
11112
NPK International
NPKI
$1.21B
$121K ﹤0.01%
39,079
+6,964
+22% +$26.7K
TCS
11113
CALL
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$121K ﹤0.01%
1,293
+286
+28% +$32.4K
LILM
11114
PUT
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$121K ﹤0.01%
51,300
-37,900
-42% -$119K
THRN
11115
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$121K ﹤0.01%
+24,974
New +$152K
ACR
11116
PUT
ACRES Commercial Realty
ACR
$102M
$120K ﹤0.01%
14,700
-5,200
-26% -$56K
AKA icon
11117
a.k.a. Brands
AKA
$120M
$120K ﹤0.01%
3,622
-2,519
-41% -$111K
KLXE icon
11118
KLX Energy Services
KLXE
$35.3M
$120K ﹤0.01%
27,680
+6,118
+28% +$32.6K
LFWD icon
11119
ReWalk Robotics
LFWD
$21M
$120K ﹤0.01%
1,526
-106
-6% -$9.02K
TETEU
11120
DELISTED
Technology & Telecommunication Acquisition Corporation Unit
TETEU
$120K ﹤0.01%
11,871
-5,268
-31% -$53.3K
FSTX
11121
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$120K ﹤0.01%
+19,100
New +$64.3K
ARBK
11122
CALL
Argo Blockchain
ARBK
$42.1M
$119K ﹤0.01%
146
-283
-66% -$410K
BBAI icon
11123
CALL
BigBear.ai
BBAI
$1.57B
$119K ﹤0.01%
32,300
-60,700
-65% -$473K
COMP icon
11124
PUT
Compass
COMP
$9.99B
$119K ﹤0.01%
33,100
-22,300
-40% -$122K
CYD icon
11125
China Yuchai International
CYD
$1.7B
$119K ﹤0.01%
+13,460
New +$140K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.